Release no. 36/2010

Copenhagen and Oslo, 30th December, 2010, 2010-12-30 13:31 CET (GLOBE NEWSWIRE)
--The financial calendar for Affitech A/S, (NASDAQ OMX: AFFI) for 2011 is as
follows

31st March, 2011 Annual Report 2010

28th April, 2011 Annual General Meeting

26th May, 2011 Interimfinancial report for 1st quarter
2011

25th August, 2011 Interim financial report for 2nd quarter 2011

17th November, 2011 Interim financial report for 3rd quarter 2011



About Affitech

Affitech ASis a publicly traded (NASDAQ OMX Copenhagen) human therapeutic
antibody company based in Copenhagen, Denmark with R&D facilities in Oslo,
Norway. The company utilizes a range of proprietary antibody technologies for
the discovery of fully human antibodies for application in oncology,
inflammation and other disease areas. CBAS™ (Cell Based Antibody Selection) is
Affitech's premier discovery engine for the isolation of lead antibodies to
cell surface molecules in situ. Several of the Company's proprietary product
candidates were generated by CBAS™. Further information is available at
www.affitech.com.

Randi Krogsgaard, Corporate Communications & IR
Tel # +45 2320 1001, e-mail: [email protected]

101230_financial_calendar_PR_36_UK.pdf